As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.
Researchers at the University of Michigan are developing a pill that makes tumors light up when exposed to infrared light, and they have demonstrated that the concept works in mice.
Mammography is an imprecise tool. About a third of breast cancer patients treated with surgery or chemotherapy have tumors that are benign or so slow-growing that they would never have become life-threatening, according to a study out of Denmark last year. In other women, dense breast tissue hides the presence of lumps and results in deaths from treatable cancers. All that, and mammograms are notoriously uncomfortable.
“We overspend $4 billion per year on the diagnosis and treatment of cancers that women would never die from,” said Greg Thurber, U-M assistant professor of chemical engineering and biomedical engineering, who led the team. “If we go to molecular imaging, we can see which tumors need to be treated.”
The move could also catch cancers that would have gone undetected. Thurber’s team uses a dye that responds to infrared light to tag a molecule commonly found on tumor cells, in the blood vessels that feed tumors and in inflamed tissue. By providing specific information on the types of molecules on the surface of the tumor cells, physicians can better distinguish a malignant cancer from a benign tumor.
Compared to visible light, infrared light penetrates the body easily—it can get to all depths of the breast without an X-ray’s tiny risk of disrupting DNA and seeding a new tumor. Using a dye delivered orally rather than directly into a vein also improves the safety of screening, as a few patients in 10,000 can have severe reactions to intravenous dyes. These small risks turn out to be significant when tens of millions of women are screened every year in the U.S. alone.
But it’s not easy to design a pill that can carry the dye to the tumor.
“To get a molecule absorbed into the bloodstream, it needs to be small and greasy. But an imaging agent needs to be larger and water-soluble. So you need exact opposite properties,” Thurber said.
Fortunately, they weren’t the only people looking for a molecule that could get from the digestive system to a tumor. The pharmaceutical company Merck was working on a new treatment for cancer and related diseases. They got as far as phase II clinical trials demonstrating its safety, but unfortunately, it wasn’t effective.
“It’s actually based on a failed drug,” Thurber said. “It binds to the target, but it doesn’t do anything, which makes it perfect for imaging.”
The targeting molecule has already been shown to make it through the stomach unscathed, and the liver also gives it a pass, so it can travel through the bloodstream. The team attached a molecule that fluoresces when it is struck with infrared light to this drug. Then, they gave the drug to mice that had breast cancer, and they saw the tumors light up.
The research is described in a study in the journal Molecular Pharmaceutics, titled, “Oral administration and detection of a near-infrared molecular imaging agent in an orthotopic mouse model for breast cancer screening.”
The Latest on: Breast cancer diagnosis
via Google News
The Latest on: Breast cancer diagnosis
- Breast cancer survivor credits journey to mammograms, advances in breast cancer researchon February 27, 2020 at 7:26 pm
BATON ROUGE, La. (WAFB) - Less than one year ago, Louann Bombet went in for her annual mammogram. That’s when her doctor noticed something suspicious and asked her to come back for a follow up ...
- Breast Cancer Conference Brings Young Survivors Togetheron February 27, 2020 at 7:03 pm
brings its fifth annual conference to Los Angeles, California, March 6-8, 2020, where it will host more than 600 young adults affected by breast cancer and their co-survivor support networks. Online ...
- Augusta woman creates crowns made of bedazzled bras for "Boobie Queens" going through breast cancer treatmenton February 27, 2020 at 7:37 am
Nearly 12% of women in the US will be diagnosed with breast cancer in their life, but one Augusta woman is trying to turn each case into something a little more lighthearted.
- How counselling can help breast cancer patients: Zulu women share their storieson February 27, 2020 at 6:22 am
Breast cancer is the most common cancer and the leading cause of cancer-related deaths in women around the world. It is also the most commonly diagnosed cancer in South African women, accounting for ...
- Keytruda shows promise against aggressive breast canceron February 27, 2020 at 6:17 am
The immunotherapy drug Keytruda might offer a new treatment option to women with an aggressive form of breast cancer, a clinical trial suggests. The study found that for women with "triple-negative" ...
- VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatmenton February 27, 2020 at 2:26 am
Compared to controls, VEGF-A/VEGF-A165b ratios were decreased in patients before and after chemotherapy. Our data suggests that circulating VEGF-A165b is significantly reduced in women with primary ...
- Drug Shows Promise Against Aggressive Breast Canceron February 26, 2020 at 3:56 pm
WEDNESDAY, Feb. 26, 2020 (HealthDay News) -- The immunotherapy drug Keytruda might offer a new treatment option to women with an aggressive form of breast cancer, a clinical trial suggests. The study ...
- Virginia Woman Survives Breast Cancer With Experimental Vaccineon February 26, 2020 at 3:30 pm
Seinfeld’s breast cancer was very aggressive. Diagnosed with metastatic breast cancer in 2006, the Annandale woman faced a dire diagnosis. As the cancer spread to her liver, she searched for new ...
- “Male Breast Cancer Was Foreign to Me. Next Thing I Knew, I Was Getting a Double Mastectomy.”on February 26, 2020 at 8:41 am
I was diagnosed with breast cancer in 2016. I had major surgery. I went through six rounds of chemo and lost my hair. I had to have mammograms. I worried about whether or not I’d be able to have kids ...
via Bing News